Saravanabhavan Thangavel

9PUBLICATIONS
6CO-AUTHORS
Regenerative medicine (incl. stem cells)Medical molecular engineering of nucleic acids and proteinsGene and molecular therapyHaematologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 02, 2025
Engineering biomimetic bone marrow niche with gene modified mesenchymal stromal cells for ex vivo culture of human hematopoietic stem and progenitor cells.

Sevanthy Suresh, Vigneshwaran Venkatesan, Manoj Kumar K Azhagiri

|Mar 03, 2025
Advancing Precision Medicine: Recent Innovations in Gene Editing Technologies.

Abhijith Koodamvetty, Saravanabhavan Thangavel

|Dec 31, 2024
Enhanced fetal hemoglobin production via dual-beneficial mutation editing of the HBG promoter in hematopoietic stem and progenitor cells for β-hemoglobinopathies.

Prathibha Babu Chandraprabha, Manoj Kumar K Azhagiri, Vigneshwaran Venkatesan

|Sep 28, 2024
Endocytosis as a critical regulator of hematopoietic stem cell fate -implications for hematopoietic stem cell and gene therapy.

Prathibha Babu Chandraprabha, Saravanabhavan Thangavel

|Sep 10, 2021
Homology-directed gene-editing approaches for hematopoietic stem and progenitor cell gene therapy.

Manoj Kumar K Azhagiri, Prathibha Babu, Vigneshwaran Venkatesan

|Sep 06, 2021
Preferential Expansion of Human CD34+CD133+CD90+ Hematopoietic Stem Cells Enhances Gene-Modified Cell Frequency for Gene Therapy.

Abisha Crystal Christopher, Vigneshwaran Venkatesan, Karthik V Karuppusamy

Pageof 2